A study on the tissue responsiveness to short term exogenous growth hormone in children with idiopathic short stature in relation to their response to long-term treatment.
Phase of Trial: Phase IV
Latest Information Update: 06 Jan 2009
At a glance
- Drugs Somatrogon (Primary)
- Indications Short stature
- Focus Therapeutic Use
- Sponsors Pfizer
- 06 Jan 2009 New trial record.